Cuprina Holdings Announces Closing of Underwriter’s Over-Allotment Option in Connection with Initial Public Offering

Core Viewpoint - Cuprina Holdings (Cayman) Limited successfully closed the sale of an additional 450,000 Class A ordinary shares at the IPO price of $4.00 per share, raising a total of$13,800,000 in gross proceeds, including previous IPO proceeds of $12,000,000 [1] Group 1: Offering Details - The Offering was conducted under the Company's registration statement on Form F-1, which was declared effective by the U.S. Securities and Exchange Commission on March 31, 2025 [3] - R. F. Lafferty & Co., Inc. acted as the sole book-running manager for the Offering [2] Group 2: Company Overview - Cuprina is a Singapore-based biomedical and biotechnology company focused on developing and commercializing products for chronic wound management and infertility, as well as cosmeceuticals for health and beauty [5] - The company utilizes materials derived from natural sources to create wound care products that meet international standards [5]